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A tandem Michael addition/ylide olefination for the rapid creation of highly functionalized cyclo-
hexadiene is developed. The tandem annulation reactions afford versatile cyclohexadienes in good to
excellent isolated yields. This method has been successfully applied to the synthesis of three biologically
active molecules.
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Scheme 1. Condensation reaction of crotonate arsonium ylide with crotonal.1. Introduction
Cyclohexadienes are very important subunits in a number of
biologically active compounds1 such as antibacterially active agent
A,1a antimicrobially active agent B,1c and calcium channel modu-
lator C,1e as well as versatile intermediates2 in organic synthesis
(Fig. 1). Although several synthetic methods have been devel-
oped,3,2a a few are involved in the direct synthesis with high se-
lectivity. Ylide reactions have been developed as one of the
powerful approaches for the preparation of alkenes,4 cyclopro-
panes,5 epoxides,5a,d,6 and aziridines5b,c,7 due to its unambiguous
positioning and good stereoselectivity. Allylic phosphorus ylides
have been employed for the construction of cyclohexadiene de-
rivatives via ylide-initiated Michael addition/olefination reaction,8
however, low yields (<50%) were obtained in the reaction of the
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All rights reserved.carbonyl compounds.8c The reactions of crotonate arsonium ylide
with conjugate aldehydes were also documented but afforded
a mixture of Wittig products and cyclohexadienes (Scheme 1).8aIn a previous study on ylide chemistry,9 we developed a tandem
reaction of allylic sulfur ylides with a,b-unsaturated ketones for the
preparation of functionalized multisubstituted cyclohexadiene
epoxides with multiple stereogenic centers (Scheme 2).10 Very re-
cently, we found that the extension of the sulfur ylide to the cor-
responding phosphorus ylide in the aforementioned reaction
resulted in the formation of versatile cyclohexadienes in good to
excellent yields with excellent chemoselectivities and regiose-
lectivities, and the direct Wittig olefination products did not ob-
served at all even when conjugate aldehydes were employed
(Scheme 3). Compared with the reaction of the corresponding
arsonium ylide,8a both the selectivities and the yields of cyclo-
hexadienes have been improved greatly. This reaction proves to be
useful in the synthesis of some biologically active molecules such as
fungicide. In this paper, we wish to report these results in details.
Table 2









Cs2CO3, THF, 60 °C4a: R = Me
4b: R = Et




Entry 2 R1 R2 5 Yieldb (%)
1 2a Ph Ph 5a 96
2c 2a Ph Ph 5a0 91
3 2b 4-Br–C6H4 Ph 5b 98
4 2c 4-OMe–C6H4 Ph 5c 89
5 2d 2-Br–C6H4 Ph 5d 93
6 2e 2-OMe–C6H4 Ph 5e 91
7 2f 4-CH3–C6H4 Ph 5f 96
8d 2g 3,4-(OMe)2–C6H3 4-F–C6H4 5g 99
9 2h Me Ph 5h 86
10 2i Styryl Ph 5i 71
11 2j Ph Styryl 5j 65
12 2k Ph Me 5k 72
13 2l Ph CO2Me 5l 99
14 2m Me CO2Et 5m 72
15 2n Me P(O)(OMe)2 5n 51
16e,f 2o Ph H 5o 81
17e 2p Me H 5p 76
a Reagents and conditions: Cs2CO3 (130 mg, 0.40 mmol), 4a (144 mg, 0.33 mmol)
in THF (2.5 mL), room temperature, 45 min, then 2 (0.25 mmol) in THF (2.5 mL) was
added and stirred for another 44–72 h at 60 C.
b Isolated yield.
c Using phosphonium salt 4c.
d Using phosphonium salt 4b.
e At room temperature.
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Scheme 2. Tandem Michael addition/ylide epoxidation reaction for the synthesis of
highly functionalized cyclohexadiene epoxide derivatives.
R1 = Aryl, Alkyl










_ + THF, 60 °C
Cs2CO3
4 2 5
Scheme 3. Synthesis of highly functionalized cyclohexadiene derivatives.
L.-W. Ye et al. / Tetrahedron 64 (2008) 8149–815481502. Result and discussion
Initially, it was found that allylic phosphonium salt 4a, after
treatment with tBuOK for 45 min, reacted with chalcone 2a afford-
ing cyclohexadiene 5a as a single product in 78% yield (entry 1, Table
1). To optimize this tandem Michael addition/ylide olefination re-
action, several reaction conditions were investigated using chalcone
2a as a model substrate. As shown in Table 1, both the base and the
reaction temperature influenced the yields. Compared with NaH,
both tBuOK and Cs2CO3 were better bases to promote the tandem
reaction in THF (entries 2–4, Table 1). Elevating the reaction tem-
perature from 25 to 60 C increased the yield of 5a from 84% to 96%
(entries 3, 6–7, Table 1). One-pot addition of phosphonium salt 4a,
chalcone, and base resulted in an obvious decrease of the yield
(entry 5, Table 1). Although this reaction could be performed in both
toluene and acetonitrile, THF was optimal (entries 7–9, Table 1).
Encouraged by these results, the generality of this tandem re-
action was examined by evaluating various a,b-unsaturated car-
bonyl compounds under the optimal conditions. As shown in Table
2, both aryl and alkyl substituted a,b-unsaturated ketones are good
substrates to give the cyclohexadiene derivatives with excellentTable 1













Entry Solvent T (C) Base Yieldb (%)
1c THF 25 tBuOK 78
2 THF 25 tBuOK 83
3 THF 25 Cs2CO3 84
4 THF 25 NaH 26
5d THF 25 Cs2CO3 43
6 THF 50 Cs2CO3 89
7 THF 60 Cs2CO3 96
8 CH3CN 60 Cs2CO3 73
9 CH3C6H5 60 Cs2CO3 48
a Reagents and conditions: base (0.40 mmol), 4a (144 mg, 0.33 mmol) in solvent
(2.5 mL), room temperature, 45 min, then 2a (52 mg, 0.25 mmol) in solvent (2.5 mL)
was added and stirred for further 24–48 h at 25–60 C.
b Isolated yield.
c Base (1.2 equiv).
d One-pot addition of 4a, Cs2CO3, and 2a.chemoselectivities and regioselectivities in good to excellent yields
(65–99%, entries 1–12, Table 2). Chalcones gave excellent results,
and both electron-donating and electron-withdrawing groups on
the aryl ring proved to be well-tolerated (entries 1–8, Table 2). (E)-
Methyl-2-oxo-4-phenylbut-3-enoate 2l, (E)-ethyl-2-oxopent-3-
enoate 2m, and but-2-enoyl-phosphonic acid dimethyl ester 2n
also gave the desired cyclohexadienes in good yields (entries 13–15,
Table 2). It is worth noting that a,b-unsaturated aldehydes 2o and
2p furnished the desired cyclohexadienes in good yields (entries
16–17, Table 2) and the direct Wittig olefination products were not
observed. Thus, the current reaction provides a highly efficient
method to construct the cyclohexadiene backbone with multi-
functional groups in one step.
2-Benzylidene-1,3-diphenyl-propane-1,3-dione 2q reacted with
allylic phosphonium salt 4a to furnish multisubstituted cyclo-
hexadiene 5q in 66% yield (Eq. 1). Noticeably, the diaster-


















The products were characterized by 1H NMR, 13C NMR, ele-
mental analysis, and mass spectra. Products 5d and 5q were further
confirmed by X-ray analysis (Fig. 2). The relative configuration of 5q
was determined by 1H NMR as well as X-ray analysis, in which the
substituted groups are located in trans-position.
This method proves to be very useful in organic synthesis.11,2a,b,d
As shown in Scheme 4, for example, reduction of 5a with DIBAL-H,
5d
5q
Figure 2. Molecular structure of compounds 5d and 5q.
92% yield (two steps)
1) DIBAL-H, DCM, -78 °C



























































Scheme 5. A possible mechanism.
L.-W. Ye et al. / Tetrahedron 64 (2008) 8149–8154 8151followed by Dess–Martin oxidation, provided biologically active
compound 61a in 92% yield. Oxidation of 5g with dichloro-
dicyanoquinone (DDQ) afforded the fungicide 712 in 94% yield. In
addition, the reaction of allylic phosphonium salt 4d with chalcone
2r (THF, 1.6 equiv of Cs2CO3, rt; 59%), followed by DDQ oxidation
(DDQ, toluene, 120 C; 96%), afforded compound 8, which could be
easily transformed to proapoptotically active compound 9 by
demethylation with BBr3.
13
The present reaction could be accounted by a proposed mech-
anism as shown in Scheme 5. Ylide I, generated in situ from the
corresponding phosphonium salt 4a, underwent an intermolecular
Michael addition with a,b-unsaturated ketones to form in-
termediate II. Proton transfer of intermediate III, followed by an
intramolecular ylide olefination afforded the desired cyclo-
hexadiene derivative 5. A clear mechanism waits for further study.3. Conclusion
In summary, we have developed a tandem Michael addition/
ylide olefination reaction, providing an easy access to highly
functionalized cyclohexadiene derivatives in good to excellent
yields. The reaction displayed a good substrate scope and pro-
ceeded with excellent chemoselectivity and regioselectivity. The
applications of this reaction in the synthesis of biologically active
compounds 6, 7, and 9 have been achieved from readily available
starting materials under mild conditions. Further investigations on
its asymmetric version are in progress in our laboratory.
4. Experimental
4.1. General
All reactions were carried out under N2 unless otherwise noted.
All solvents were purified according to standard methods prior to
use. 1H NMR and 13C NMR spectra were recorded in chloroform-d3
on a VARIAN Mercury 300.
L.-W. Ye et al. / Tetrahedron 64 (2008) 8149–815481524.2. Representative procedure for the synthesis of highly
functionalized cyclohexadiene derivatives
4.2.1. Preparation of 4,6-diphenyl-cyclohexa-1,3-dienecarboxylic
acid methyl ester 5a
Cs2CO3 (130 mg, 0.40 mmol) was added to a solution of phos-
phonium salt 4a (144 mg, 0.33 mmol) in THF (2.5 mL), and the
resulting mixture was stirred at room temperature for 45 min.
Chalcone 2a (52 mg, 0.25 mmol) in THF (2.5 mL) was added and the
reaction mixture was stirred at 60 C for 48 h. After the reaction was
complete (monitored by TLC), the reaction mixture was passed
through a glass funnel with a thin layer of silica gel, and eluted with
ethyl acetate. The filtrate was concentrated and the residue was pu-
rified by flash column chromatography to afford cyclohexadiene 5a
as white solid (mp 96–97 C). Yield 70 mg (96%); 1H NMR (300 MHz,
CDCl3, TMS): d 7.44–7.13 (m,11H), 6.53 (dd, J¼6.0 and 3.0 Hz,1H), 4.18
(dd, J¼1.8 and 9.9 Hz, 1H), 3.70 (s, 3H), 3.29–3.19 (m, 1H), 3.02 (dd,
J¼18 and 2.7 Hz, 1H); 13C NMR (75 MHz, CDCl3): d 167.4, 158.7, 142.6,
141.7, 139.7, 134.6, 128.5, 128.4, 128.3, 127.1, 126.6, 125.5, 119.7, 51.7,
36.8, 34.5. IR n/cm1: 2948 (m),1705 (s),1561 (m),1493 (m),1082 (m),
747 (m), 697; MS (EI, m/z, rel intensity): 290 (Mþ, 77.4), 231 (100).
Anal. calcd for C20H18O2: C, 82.73; H, 6.25. Found: C, 82.83; H, 6.18.
4.2.2. 4,6-Diphenyl-cyclohexa-1,3-dienecarboxylic acid tert-butyl
ester 5a0
Yield 91% (colorless oil, 51 h); 1H NMR (300 MHz, CDCl3, TMS):
d 7.42–7.39 (m, 2H), 7.33–7.15 (m, 9H), 6.51 (dd, J¼6.0 and 2.7 Hz,
1H), 4.12 (dd, J¼2.1 and 9.9 Hz, 1H), 3.27–3.17 (m, 1H), 2.99 (dd,
J¼17.7 and 2.7 Hz, 1H), 1.40 (s, 9H); 13C NMR (75 MHz, CDCl3):
d 166.3, 143.3, 140.9, 139.9, 133.6, 130.6, 128.5, 128.3, 128.1, 127.1,
126.4, 125.5, 119.8, 80.3, 37.4, 34.6, 28.0. IR n/cm1: 2926 (m), 1700
(s), 1561 (m), 1494 (m), 1367 (m), 751 (m), 697 (m); MS (EI, m/z, rel
intensity): 332 (Mþ, 6.8), 230 (100). HRMS (EI) calcd for C23H24O2
(Mþ): 332.1776. Found: 332.1765.
4.2.3. 6-(4-Bromo-phenyl)-4-phenyl-cyclohexa-1,3-
dienecarboxylic acid methyl ester 5b
Yield 98% (a white solid, mp 141–142 C, 57 h); 1H NMR
(300 MHz, CDCl3, TMS): d 7.43–7.23 (m, 8H), 7.16 (d, J¼8.4 Hz, 2H),
6.52 (dd, J¼6.0 and 3.0 Hz, 1H), 4.12 (d, J¼9.9 Hz, 1H), 3.70 (s, 3H),
3.27–3.17 (m, 1H), 2.96 (dd, J¼17.7 and 1.8 Hz, 1H); 13C NMR
(75 MHz, CDCl3): d 167.2, 141.6 (0), 141.5 (8), 139.4, 134.8, 131.5,
128.9, 128.5 (3), 128.4 (7), 128.0, 125.5, 120.5, 119.6, 51.7, 36.4, 34.4.
IR n/cm1: 2948 (m), 1705 (s), 1561 (m), 1485 (m), 1368 (m), 778
(m), 693 (m), 492 (m); MS (ESI, positive mode, m/z): 425
(MþMeOHþNaþ), 423 (MþMeOHþNaþ), 393 (MþNaþ), 391
(MþNaþ), 371 (MþHþ), 369 (MþHþ). HRMS (EI) calcd for
C20H17O2Br (M
þ): 368.0412. Found: 368.0418.
4.2.4. 6-(4-Methoxy-phenyl)-4-phenyl-cyclohexa-1,3-diene-
carboxylic acid methyl ester 5c
Yield 89% (a yellow solid, mp 157–158 C, 56 h); 1H NMR
(300 MHz, CDCl3, TMS): d 7.43–7.19 (m, 8H), 6.75 (d, J¼8.7 Hz, 2H),
6.52 (dd, J¼6.0 and 3.0 Hz, 1H), 4.13 (d, J¼9.6 Hz, 1H), 3.73 (s, 3H),
3.71 (s, 3H), 3.27–3.17 (m, 1H), 2.99 (dd, J¼17.4 and 1.5 Hz, 1H); 13C
NMR (75 MHz, CDCl3): d 167.5, 158.3, 141.7, 139.8, 134.8, 134.3, 128.9,
128.5, 128.3, 128.1, 125.6, 119.6, 113.8, 55.1, 51.7, 36.1, 34.7. IR n/cm1:
2949 (m), 1709 (s),1608 (m), 1560 (m),1510 (m), 1435 (m), 1082 (m),
831 (m), 760 (m), 696 (m); MS (ESI, positive mode, m/z): 375
(MþMeOHþNaþ), 343 (MþNaþ). Anal. calcd for C21H20O3: C, 78.73;
H, 6.29. Found: C, 78.80; H, 6.29.
4.2.5. 6-(2-Bromo-phenyl)-4-phenyl-cyclohexa-1,3-
dienecarboxylic acid methyl ester 5d
Yield 93% (a white solid, mp 143–144 C, 66 h); 1H NMR
(300 MHz, CDCl3, TMS): d 7.58–7.55 (m, 2H), 7.37–7.22 (m, 5H),7.17–7.08 (m, 2H), 7.04–6.98 (m, 1H), 6.54 (dd, J¼6.3 and 3.0 Hz, 1H),
4.67 (dd, J¼10.8 and 1.8 Hz, 1H), 3.68 (s, 3H), 3.25–3.15 (m, 1H), 2.99
(dd, J¼17.7 and 2.1 Hz, 1H); 13C NMR (75 MHz, CDCl3): d 167.1, 141.7,
140.0, 139.6, 136.0, 133.3, 128.5, 128.4, 128.3, 128.2, 127.6, 127.3,
125.5, 123.7, 119.5, 51.8, 35.9, 32.9. IR n/cm1: 2950 (m), 1707 (s),
1560 (m), 1435 (m), 1269 (m), 751 (m), 692 (m), 671 (m); MS (ESI,
positive mode, m/z): 425 (MþMeOHþNaþ), 423 (MþMeOHþNaþ),
393 (MþNaþ), 391 (MþNaþ), 371 (MþHþ), 369 (MþHþ). Anal. calcd
for C20H17O2Br: C, 65.05; H, 4.64. Found: C, 64.72; H, 4.69.
4.2.6. 6-(2-Methoxy-phenyl)-4-phenyl-cyclohexa-1,3-
dienecarboxylic acid methyl ester 5e
Yield 91% (a white solid, mp 161–162 C, 68 h); 1H NMR
(300 MHz, CDCl3, TMS): d 7.51 (d, J¼5.7 Hz, 1H), 7.36–7.21 (m, 5H),
7.13 (t, J¼7.8 Hz,1H), 7.05 (d, J¼7.8 Hz,1H), 6.85 (d, J¼8.1 Hz,1H), 6.76
(t, J¼7.5 Hz,1H), 6.50 (dd, J¼5.7 and 2.4 Hz,1H), 4.66 (d, J¼8.7 Hz,1H),
3.89 (s, 3H), 3.67 (s, 3H), 3.19–3.09 (m,1H), 2.95 (dd, J¼17.7 and 1.2 Hz,
1H); 13C NMR (75 MHz, CDCl3): d 167.4, 156.5, 142.2, 140.0, 135.7,
129.1, 128.3, 128.1, 127.9, 127.5 (0), 127.4 (6), 125.5, 120.1, 119.5, 110.7,
55.5, 51.6, 33.1, 29.7. IR n/cm1: 2950 (m),1709 (s),1565 (m),1488 (m),
1433 (m), 1028 (m), 856 (m), 760 (m), 699 (m); MS (ESI, positive
mode, m/z): 375 (MþMeOHþNaþ), 343 (MþNaþ), 321 (MþHþ). Anal.
calcd for C21H20O3: C, 78.73; H, 6.29. Found: C, 78.88; H, 6.29.
4.2.7. 4-Phenyl-6-p-tolyl-cyclohexa-1,3-dienecarboxylic acid
methyl ester 5f
Yield 96% (colorless oil, 66 h); 1H NMR (300 MHz, CDCl3, TMS):
d 7.41–7.38 (m, 3H), 7.38–7.16 (m, 5H), 7.02 (d, J¼8.1 Hz, 2H), 6.53–
6.50 (m, 1H), 4.15 (d, J¼9.9 Hz, 1H), 3.70 (s, 3H), 3.27–3.17 (m, 1H),
3.00 (dd, J¼17.7 and 1.5 Hz, 1H), 2.25 (s, 3H); 13C NMR (75 MHz,
CDCl3): d 167.4, 141.7, 139.7 (3), 139.6 (7), 136.1, 134.4, 129.1, 128.7,
128.4, 128.2, 127.0, 125.5, 119.6, 51.6, 36.5, 34.6, 20.9. IR n/cm1:
2948 (m), 1718 (s), 1688 (m), 1560 (m), 1434 (m), 1081 (m), 818 (m),
759 (m), 693 (m); MS (ESI, positive mode, m/z): 359
(MþMeOHþNaþ), 327 (MþNaþ), 305 (MþHþ). HRMS (EI) calcd for
C21H20O2 (M
þ): 304.1463. Found: 304.1465.
4.2.8. 6-(3,4-Dimethoxy-phenyl)-4-(4-fluoro-phenyl)-cyclohexa-
1,3-dienecarboxylic acid methyl ester 5g
Yield 99% (pale yellow oil, 63 h); 1H NMR (300 MHz, CDCl3,
TMS): d 7.40–7.35 (m, 3H), 7.02–6.78 (m, 4H), 6.70 (d, J¼8.4 Hz, 1H),
6.45 (dd, J¼2.7 and 6.0 Hz, 1H), 4.22–4.09 (m, 3H), 3.79 (s, 3H), 3.78
(s, 3H), 3.25–3.15 (m, 1H), 2.96 (dd, J¼17 and 1.8 Hz, 1H), 1.25 (t,
J¼7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): d 166.7, 148.5, 147.5, 140.5
(d, J¼0.9 Hz), 135.8 (d, J¼3.5 Hz), 135.3, 133.6, 129.0, 127.1 (d,
J¼7.5 Hz), 119.1 (d, J¼2.1 Hz), 118.8, 115.4, 115.1, 110.8, 110.3, 60.3,
55.5 (0), 55.4 (8), 36.3, 34.6, 14.0. IR n/cm1: 2934 (m), 1700 (s), 1599
(m), 1561 (m), 1509 (m), 1464 (m), 1230 (m), 1028 (m), 830 (m), 771
(m); MS (EI, m/z, rel intensity): 382 (Mþ, 100), 309 (92.9). HRMS (EI)
calcd for C23H23FO4 (M
þ): 382.1580. Found: 382.1578.
4.2.9. 6-Methyl-4-phenyl-cyclohexa-1,3-dienecarboxylic acid
methyl ester 5h
Yield 86% (colorless oil, 44 h); 1H NMR (300 MHz, CDCl3, TMS):
d 7.42 (d, J¼7.2 Hz, 2H), 7.31–7.17 (m, 3H), 7.05 (d, J¼6.3 Hz, 1H),
6.36 (dd, J¼5.7 and 2.7 Hz, 1H), 3.70 (s, 3H), 2.94–2.76 (m, 2H), 2.54
(d, J¼17 Hz, 1H), 0.95 (d, J¼6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3):
d 167.6, 141.3, 140.3, 132.8, 131.5, 128.5, 128.1, 125.4, 119.0, 51.5, 33.3,
26.5, 17.7. IR n/cm1: 2954 (m), 1705 (s), 1560 (m), 1435 (m), 1089
(m), 753 (m), 693 (m); MS (ESI, positive mode, m/z): 229 (MþHþ).
HRMS (EI) calcd for C15H16O2 (M
þ): 228.1150. Found: 228.1147.
4.2.10. 4-Phenyl-6-styryl-cyclohexa-1,3-dienecarboxylic acid
methyl ester 5i
Yield 71% (colorless oil, 60 h); 1H NMR (300 MHz, CDCl3, TMS):
d 7.52 (d, J¼6.9 Hz, 2H), 7.39–7.13 (m, 9H), 6.52–6.44 (m, 2H), 6.23
L.-W. Ye et al. / Tetrahedron 64 (2008) 8149–8154 8153(dd, J¼15.9 and 7.5 Hz, 1H), 3.78 (s, 3H), 3.71 (t, J¼7.5 Hz, 1H), 3.07–
2.89 (m, 2H); 13C NMR (75 MHz, CDCl3): d 167.3, 141.8, 139.7, 137.3,
133.9, 129.9, 128.7, 128.6, 128.4, 128.3, 127.8, 127.1, 126.2, 125.6,
119.5, 51.7, 34.8, 32.0. IR n/cm1: 2948 (m), 1705 (s), 1557 (m), 1434
(m), 1267 (m), 1085 (s), 757 (m), 693 (m); MS (ESI, positive mode,
m/z): 371 (MþMeOHþNaþ), 339 (MþNaþ), 317 (MþHþ). HRMS (EI)
calcd for C22H20O2 (M
þ): 316.1463. Found: 316.1458.
4.2.11. 6-Phenyl-4-styryl-cyclohexa-1,3-dienecarboxylic acid
methyl ester 5j
Yield 65% (a white solid, mp 113–114 C, 58 h); 1H NMR
(300 MHz, CDCl3, TMS): d 7.43–7.12 (m, 11H), 6.89 (d, J¼16.5 Hz,1H),
6.67 (d, J¼16.2 Hz, 1H), 6.24 (d, J¼6.0 Hz, 1H), 4.17 (t, J¼5.7 Hz, 1H),
3.70 (s, 3H), 2.97 (d, J¼5.7 Hz, 2H); 13C NMR (75 MHz, CDCl3): d 167.3,
143.2,140.4,136.8,134.5,130.7,129.6,129.4,128.9,128.7,128.4,128.1,
127.1, 126.7, 124.1, 51.7, 36.7, 31.2. IR n/cm1: 2948 (m), 1704 (s), 1542
(m),1434 (m), 1263 (m),1074 (s), 750 (m), 697 (m); MS (ESI, positive
mode, m/z): 371 (MþMeOHþNaþ), 339 (MþNaþ), 317 (MþHþ).
HRMS (EI) calcd for C22H20O2 (M
þ): 316.1463. Found: 316.1465.
4.2.12. 4-Methyl-6-phenyl-cyclohexa-1,3-dienecarboxylic acid
methyl ester 5k
Yield 72% (a white solid, mp 70–71 C, 72 h); 1H NMR (300 MHz,
CDCl3, TMS): d 7.26–7.17 (m, 6H), 5.92–5.90 (m, 1H), 4.00 (d,
J¼10.2 Hz, 1H), 3.67 (s, 3H), 2.88 (dd, J¼18.0 and 10.8 Hz, 1H), 2.36
(d, J¼18.0 Hz, 1H), 1.79 (s, 3H); 13C NMR (75 MHz, CDCl3): d 167.6,
143.5, 142.7, 134.9, 128.3, 127.0, 126.5 (1), 126.4 (6), 118.9, 51.5, 37.4,
36.7, 23.8. IR n/cm1: 2949 (m), 1709 (s), 1589 (s), 1435 (m), 1076
(m), 760 (m), 699 (m); MS (ESI, positive mode, m/z): 283
(MþMeOHþNaþ), 251 (MþNaþ), 229 (MþHþ). HRMS (EI) calcd for
C15H16O2 (M
þ): 228.1150. Found: 228.1152.
4.2.13. 5-Phenyl-cyclohexa-1,3-diene-1,4-dicarboxylic acid
dimethyl ester 5l
Yield 99% (a white solid, mp 77–78 C, 46 h); 1H NMR (300 MHz,
CDCl3, TMS): d 7.36 (d, J¼6.3 Hz, 1H), 7.27–7.16 (m, 6H), 4.17 (dd,
J¼9.9 and 2.4 Hz, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 3.08–2.87 (m, 2H);
13C NMR (75 MHz, CDCl3): d 166.7, 166.6, 141.4, 134.5, 132.3, 131.2,
128.5, 127.1, 126.9, 52.0 (4), 51.9 (6), 36.5, 30.7. IR n/cm1: 2951 (m),
1712 (s), 1641 (m), 1435 (m), 1092 (m), 734 (m), 700 (m); MS (EI,
m/z, rel intensity): 272 (Mþ, 44.8), 213 (100). HRMS (EI) calcd for
C16H16O4 (M
þ): 272.1049. Found: 272.1052.
4.2.14. 5-Methyl-cyclohexa-1,3-diene-1,4-dicarboxylic acid 1-ethyl
ester 4-methyl ester 5m
Yield 72% (colorless oil, 54 h); 1H NMR (300 MHz, CDCl3, TMS):
d 7.09–7.03 (m, 2H), 4.25 (q, J¼7.2 Hz, 2H), 3.78 (s, 3H), 3.01–2.90
(m, 1H), 2.71–2.50 (m, 2H), 1.33 (t, J¼7.2 Hz, 3H), 0.99 (d, J¼7.2 Hz,
3H); 13C NMR (75 MHz, CDCl3): d 166.8 (7), 166.8 (5), 137.9, 131.4,
130.4, 60.8, 51.9, 29.2, 26.3, 17.8, 14.2. IR n/cm1: 2959 (m), 1709 (s),
1437 (m), 1259 (m), 1095 (m), 740 (m); MS (EI, m/z, rel intensity):




dienecarboxylic acid methyl ester 5n
Yield 51% (colorless oil, 52 h); 1H NMR (300 MHz, CDCl3, TMS):
d 7.06–6.90 (m, 2H), 3.82 (s, 3H), 3.79 (d, J¼6.0 Hz, 3H), 3.75 (d,
J¼5.7 Hz, 3H), 3.00–2.93 (m, 1H), 2.61–2.50 (m, 1H), 2.45–2.36 (m,
1H), 1.02 (d, J¼6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): d 137.6 (d,
J¼4.0 Hz), 135.1 (d, J¼10.4 Hz), 132.0 (d, J¼11.3 Hz), 129.5 (d, J¼
19.3 Hz), 126.8, 52.5 (t, J¼5.1 Hz), 52.0 (d, J¼0.9 Hz), 29.8 (d,
J¼7.9 Hz), 25.6 (d, J¼8.3 Hz), 17.3 (d, J¼1.1 Hz). IR n/cm1: 2956 (m),
1709 (s), 1438 (m), 1258 (m), 1054 (m), 827 (m); MS (ESI, positive
mode, m/z): 315 (MþMeOHþNaþ), 283 (MþNaþ), 261 (MþHþ).
HRMS (EI) calcd for C11H17O5P (M
þ): 260.0814. Found: 260.0818.4.2.16. 6-Phenyl-cyclohexa-1,3-dienecarboxylic acid
methyl ester 5o
Yield 81% (colorless oil, 56 h); 1H NMR (300 MHz, CDCl3, TMS):
d 7.29–7.17 (m, 6H), 6.18–6.12 (m, 1H), 6.02–5.96 (m, 1H), 4.01 (dd,
J¼10.5 and 1.2 Hz, 1H), 3.68 (s, 3H), 2.95–2.83 (m, 1H), 2.61–2.52
(m, 1H); 13C NMR (75 MHz, CDCl3): d 167.5, 142.6, 133.8, 131.7, 129.1,
128.3, 127.2, 126.6, 123.7, 51.7, 35.6, 32.1. IR n/cm1: 2950 (m), 1709
(s), 1575 (m), 1435 (m), 1092 (m), 699 (m); MS (EI, m/z, rel in-
tensity): 214 (Mþ, 13.8), 57 (100). HRMS (EI) calcd for C14H14O2
(Mþ): 214.0994. Found: 214.0992.
4.2.17. 6-Methyl-cyclohexa-1,3-dienecarboxylic acid
methyl ester 5p8f
Yield 76% (colorless oil, 65 h); 1H NMR (300 MHz, CDCl3, TMS):
d 6.98–6.96 (m, 1H), 6.03 (t, J¼3.0 Hz, 2H), 3.76 (s, 3H), 2.85–2.75
(m, 1H), 2.57–2.48 (m, 1H), 2.22–2.14 (m, 1H), 0.99 (d, J¼7.2 Hz, 3H);




Yield 66% (a white solid, mp 125–126 C, 70 h); 1H NMR
(300 MHz, CDCl3, TMS): d 8.07 (d, J¼7.2 Hz, 2H), 7.67–7.42 (m, 6H),
7.39–7.24 (m, 8H), 6.92 (d, J¼6.0 Hz, 1H), 4.95 (s, 1H), 4.38 (s, 1H),
3.63 (s, 3H); 13C NMR (75 MHz, CDCl3): d 195.7, 166.6, 141.7, 139.2,
138.9, 134.5, 134.0, 133.5, 129.0, 128.9 (3), 128.9 (2), 128.6, 128.5,
127.5, 127.2, 127.1, 125.6, 123.0, 52.1, 51.7, 41.3. IR n/cm1: 2948 (m),
1707 (s), 1596 (m), 1436 (m), 1260 (m), 1082 (s), 751 (m), 697 (m);
MS (ESI, positive mode, m/z): 395 (MþHþ). Anal. calcd for C27H22O3:
C, 82.21; H, 5.62. Found: C, 82.58; H, 5.59.
4.2.19. 1,3-Dimethoxy-5-[5-(4-methoxy-phenyl)-cyclohexa-2,4-
dienyl]-benzene 5r
Yield 59% (a white solid, mp 74–75 C, 31 h); 1H NMR (300 MHz,
CDCl3, TMS): d 7.37 (d, J¼9.0 Hz, 2H), 6.85 (d, J¼8.7 Hz, 2H), 6.50 (d,
J¼2.4 Hz, 2H), 6.35–6.28 (m, 2H), 6.22–6.16 (m, 1H), 5.85 (dd, J¼9.6
and 3.3 Hz, 1H), 3.79 (s, 3H), 3.77–3.65 (m, 7H), 2.92–2.69 (m, 2H);
13C NMR (75 MHz, CDCl3): d 160.7, 158.9, 148.0, 135.3, 133.2, 128.5,
126.1, 125.5, 118.5, 113.7, 105.6, 98.2, 55.2, 41.4, 34.6. IR n/cm1: 2930
(m), 1606 (s), 1512 (m), 1460 (m), 1154 (m), 1065 (m), 831 (m), 750
(m); MS (EI, m/z, rel intensity): 322 (Mþ, 100), 171 (53.8). Anal. calcd
for C21H22O3: C, 78.23; H, 6.88. Found: C, 78.20; H, 6.94.
4.3. Representative procedure for the synthesis of 4,
6-diphenyl-cyclohexa-1,3-dienecarbaldehyde 6
4.3.1. Preparation of 4,6-diphenyl-cyclohexa-1,3-diene-
carbaldehyde 6
DIBAL-H (1.0 M in toluene, 1.5 mL, 1.5 mmol) was added drop-
wise to a solution of 5a (145 mg, 0.50 mmol) in dry dichloro-
methane (2 mL) at 78 C. After 1 h, the reaction mixture was
warmed to 0 C and quenched with 5 mL of Rochelle’s salt solution.
The mixture was stirred vigorously for 2 h, the layers were sepa-
rated, and the aqueous layer was extracted with dichloromethane
(210 mL). The organic layers were dried with sodium sulfate and
concentrated to give the crude alcohol, which was used directly in
the next step.
In a flame-dried round bottom flask, a solution of the obtained
crude alcohol was dissolved in dichloromethane (5 mL), Dess–
Martin periodinane (DMP) (254 mg, 0.60 mmol) was added to the
solution directly and the solution was then allowed to stir at am-
bient temperature for 10 min. The solution was filtered through
Celite 545 and then concentrated in vacuo. The residue was sub-
jected to column chromatography to provide 61a as pale yellow
liquid. Yield 119 mg (92%); 1H NMR (300 MHz, CDCl3, TMS): d 9.58
(s, 1H), 7.45 (dd, J¼8.1 and 1.8 Hz, 2H), 7.36–7.05 (m, 9H), 6.63 (dd,
L.-W. Ye et al. / Tetrahedron 64 (2008) 8149–81548154J¼6.0 and 2.4 Hz, 1H), 4.22 (dd, J¼9.0 and 2.1 Hz, 1H), 3.24–3.05 (m,
2H); 13C NMR (75 MHz, CDCl3): d 192.0, 145.3, 143.4, 142.3, 139.2,
138.3, 128.9, 128.6, 128.4, 127.0, 126.7, 125.7, 119.7, 34.2, 33.9. IR
n/cm1: 2811 (m), 1667 (s), 1553 (m), 1493 (m), 1172 (m), 758 (m),
698 (m); MS (EI, m/z, rel intensity): 260 (Mþ, 100), 231 (72.1).
4.4. Representative procedure for the DDQ oxidation
4.4.1. Preparation of fungicide 7
DDQ (70 mg, 0.31 mmol) was added to a mixed solution of 5g
(96 mg, 0.25 mmol) in toluene (11 mL) and the resulting mixture
was stirred at 120 C for 35 h. After the reaction was complete
(monitored by TLC), the reaction mixture was passed through
a glass funnel with a thin layer of silica gel, and eluted with ethyl
acetate. The filtrate was concentrated and the residue was purified
by flash column chromatography to afford 712 as pale yellow oil.
Yield 94%; 1H NMR (300 MHz, CDCl3, TMS): d 7.87 (d, J¼7.5 Hz, 1H),
7.62–7.55 (m, 4H), 7.15 (t, J¼8.4 Hz, 2H), 6.92–6.89 (m, 3H), 4.14 (q,
J¼7.2 Hz, 2H), 3.93 (s, 3H), 3.89 (s, 3H), 1.08 (t, J¼7.2 Hz, 3H); 13C
NMR (75 MHz, CDCl3): d 168.6, 148.4 (d, J¼2.1 Hz), 142.7 (d,
J¼7.7 Hz), 135.9 (d, J¼3.2 Hz), 134.0, 130.3, 130.0, 129.1, 128.9, 128.8,
128.7, 125.3, 120.6, 115.9, 115.6, 111.7, 110.7, 60.9, 55.8 (2), 55.7 (9),
13.8. IR n/cm1: 2936 (m), 1709 (s), 1604 (m), 1508 (m), 1028 (m),
830 (m); MS (EI, m/z, rel intensity): 380 (Mþ, 100), 220 (12.5).
4.4.2. Preparation of compound 813
Yield 96% (pale yellow oil, 17 h); 1H NMR (300 MHz, CDCl3,
TMS): d 7.66 (d, J¼1.2 Hz, 1H), 7.65–7.39 (m, 4H), 7.16–7.06 (m, 1H),
6.90 (d, J¼9.0 Hz, 2H), 6.69 (d, J¼2.1 Hz, 2H), 6.39 (t, J¼2.4 Hz, 1H),
3.75 (s, 9H); 13C NMR (75 MHz, CDCl3): d 161.0, 143.5, 141.7, 141.3,
133.5, 129.1, 129.0, 128.2, 126.0, 125.7, 125.5, 114.2, 105.5, 99.3, 55.4,
55.3. IR n/cm1: 2960 (m), 1594 (s), 1517 (m), 1461 (m), 1247 (m),
1155 (m), 1038 (m), 794 (m), 695 (m), 574 (m); MS (EI, m/z, rel in-
tensity): 320 (Mþ, 100), 305 (10.5).
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